Brown Trout Management »

Terns Pharmaceuticals shares owned by Brown Trout Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Brown Trout Management from 13F filings

Historical chart of Brown Trout Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Brown Trout Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Brown Trout Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.1M 129k 39.76

More positions owned by Brown Trout Management

Chart Industries (GTLS)
Janus Henderson Group Ord Shs (JHG)
Arcellx Common Stock (ACLX)
Bandwidth Note 0.500% 4/0 (Principal)
Amicus Therapeutics (FOLD)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Cracker Barrel Old Ctry Stor Note 0.625% 6/1 (Principal)
Accuray Inc Del Note 3.750% 6/0 (Principal)
Sabre Glbl Note 7.320% 8/0 (Principal)
Mgp Ingredients Note 1.875%11/1 (Principal)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
The Realreal Note 1.000% 3/0 (Principal)
Rapid7 Note 0.250% 3/1 (Principal)
Nabors Inds Note 1.750% 6/1 (Principal)

View all positions for Brown Trout Management

Top funds holding Terns Pharmaceuticals

BlackRock
Adage Capital Partners GP
Vanguard Group
Vivo Capital
Vestal Point Capital
venBio Select Advisor
Citadel Advisors
Holocene Advisors
Franklin Resources
Lord, Abbett & Co
OrbiMed Advisors
Geode Capital Management
Ameriprise Financial
State Street Corporation
Acorn Capital Advisors

View all funds holding Terns Pharmaceuticals